Behavioral consequences of NMDA antagonist-induced neuroapoptosis in the infant mouse brain

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Yuede, Carla M ^a,b   Wozniak, David F ^a   Creeley, Catherine E ^a   Taylor, George T ^b   Olney, John W ^a   Farber, Nuri B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI ST LOUIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; N METHYLASPARTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DEGENERATION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DISEASE SEVERITY; EMBRYO; ENVIRONMENTAL EXPOSURE; MOUSE; NEUROAPOPTOSIS; NEUROPATHOLOGY; NONHUMAN; PERINATAL PERIOD; ANIMAL; ANIMAL BEHAVIOR; BODY WEIGHT; BRAIN; C57BL MOUSE; CONDITIONED REFLEX; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FEAR; FEMALE; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; MALE; NEWBORN; STARTLE REFLEX;

MUS; RODENTIA;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN; CONDITIONING, CLASSICAL; FEAR; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; N-METHYLASPARTATE; PHENCYCLIDINE; STARTLE REACTION;

EID: 77956193947     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011374     Document Type: Article

References (31)

1. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, et al. (1999) Blockade of glutamate receptors triggers apoptotic neurodegeneration in the developing brain. Science 283: 70-74.
2. Ikonomidou C, Bittigau P, Koch C, Genz K, Hoerster F, et al. (2001) Neurotransmitters and apoptosis in the developing brain. Biochemistry and Pharmacology 62(4): 401-5.
3. Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, et al. (2003) Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. Journal of Neuroscience 23(3): 876-82.
4. Johnson SA, Young C, Olney JW (2008) Isoflurane-induced neuroapoptosis in the developing brain of nonhypoglycemic mice. J Neurosurg Anesthesiol 20(1): 21-8.
5. Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, et al. (2000) Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287: 1056-60.
6. Dobbing J, Sands J (1979) The brain growth spurt in various mammalian species. Early Human Development 3: 79-84.
7. Wozniak DF, Hartman RE, Boyle MP, Vogt SK, Brooks AR, et al. (2004) Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults. Neurobiology of Disease 17(3): 403-14.
8. Wang C, McInnis J, Ross-Sanchez M, Shinnick-Gallagher P, Wiley JL, et al. (2001) Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience 107(4): 535-50.
9. Wiley JL, Harvey SA, Balster RL, Nicholson KL (2003) Affinity and specificity of N-methyl-D-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats. Psychopharmacology 165(4): 378-85.
10. Boctor SY, Ferguson SA (2010) Altered adult locomotor activity in rats from phencyclidine treatment on postnatal days 7, 9 and 11, but not repeated ketamine treatment on postnatal day 7. Neurotoxicology 31(1): 42-54.
11. Nakatani-Pawlak A, Yamaguchi K, Tatsumi Y, Mizoguchi H, Yoneda Y (2009) Neonatal phencyclidine treatment in mice induces behavioral, histological and neurochemical abnormalities in adulthood. Biol Pharm Bull 32(9): 1576-1583.
12. Young C, Roth KA, Klocke BJ, West T, Holtzman DM, et al. (2005) Role of caspase-3 in ethanol-induced developmental neurodegeneration. Neurobiology of Disease 20(2): 608-14.
13. Paxinos G, Halliday G, Watson C, Koutcherov Y, Wang HQ (2007) Atlas of the Developing Mouse Brain. London: Academic Press.
14. Hartman RE, Wozniak DF, Nardi A, Olney JW, Sartorius L, et al. (2001) Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Experimental Neurology 170(2): 326-44.
15. Gallitano-Mendel A, Izumi Y, Tokuda K, Zorumski CF, Howell MP, et al. (2007) The immediate early gene early growth response gene 3 mediates adaptation to stress and novelty. Neuroscience 148(3): 633-43.
16. Wozniak DF, Xiao M, Xu L, Yamada KA, Ornitz DM (2007) Impaired spatial learning and defective theta burst induced LTP in mice lacking fibroblast growth factor 14. Neurobiology of Disease 26(1): 14-26.
17. Khuchua Z, Wozniak DF, Bardgett ME, Yue Z, McDonald M, et al. (2003) Deletion of the N-terminus of murine map2 by gene targeting disrupts hippocampal ca1 neuron architecture and alters contextual memory. Neurosci-ence 119(1): 101-11.
18. Wang CZ, Johnson KM (2005) Differential effects of acute and subchronic administration on phencyclidine-induced neurodegeneration in the perinatal rat. J of Neurosci Res 81: 284-292.
19. Aggleton JP, Brown MW (1999) Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behavioral Brain Science 22: 425-489.
20. Mitchell AS, Dalrymple-Alford JC, Christie MA (2002) Spatial working memory and the brainstem cholinergic innervation to the anterior thalamus. Journal of Neuroscience 22: 1922-28.
21. Packard MG, Knowlton BJ (2002) Learning and memory functions of the Basal Ganglia. Annual Review Neuroscience 25: 563-93.
22. Young C, Jevtovic-Todorovic V, Qin YQ, Tenkova T, Wang H, et al. (2005b) Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br J Pharmacol 146(2): 189-97.
23. Fredriksson A, Archer T (2004a) Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD. Neurotoxicology Research 6(6): 435-56.
24. Fredriksson A, Archer T, Alm H, Gordh T, Eriksson P (2004b) Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behavioural Brain Research 153(2): 367-76.
25. Fredriksson A, Ponten E, Gordh T, Eriksson P (2007) Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral effects. Anesthesiology 107(3): 427-36.
26. Slikker W, Jr., Zou X, Hotchkiss CE, Divine RL, Sadovova N, et al. (2007) Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicological Science 98(1): 145-58.
27. Zou X, Patterson TA, Divine RL, Sadovova N, Zhang X, et al. (2009) Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. International Journal of Developmental Neuroscience 27(7): 727-31.
28. Brambrink A, Evers A, Avidan M, Farber NB, Smith D, et al. (2010) Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain. Anesthesiology 112(4): 834-41.
29. DiMaggio CJ, Sun L, Kakavouli A, Byrne MW, Li G (2009) Exposure to anesthesia and the risk of developmental and behavioral disorders in young children. J Neurosurg Anesthesiol 21(4): 289-91.
30. Wilder RT, Flick RP, Sprung J, Katusic SK, Barbaresi WJ, et al. (2009) Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology 110(4): 796-804.
31. Kalkman CJ, Peelen L, Moons KG, Veenhuizen M, Bruens M, et al. (2009) Behavior and development in children and age at the time of first anesthetic exposure. Anesthesiology 110(4): 805-12.